Analysing the relationship between treatment effect and underlying risk in meta-analysis: Comparison and development of approaches

Statistics in Medicine

Volumn 19, Issue 23, 2000, Pages 3251-3274

  Sharp, Stephen J ^a   Thompson, Simon G ^b  

^a GLAXOSMITHKLINE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; BLEEDING; CLINICAL TRIAL; HUMAN; META ANALYSIS; MODEL; MORTALITY; REGRESSION ANALYSIS; REVIEW; RISK; SAMPLING; SCLEROTHERAPY; STATISTICAL ANALYSIS; STATISTICAL PARAMETERS; TECHNIQUE; TREATMENT OUTCOME;

ALGORITHMS; FIBROSIS; HEMORRHAGE; HUMANS; META-ANALYSIS; RANDOMIZED CONTROLLED TRIALS; RISK; RISK ASSESSMENT; SCLEROTHERAPY; TREATMENT OUTCOME;

EID: 0034672272     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0258(20001215)19:23<3251::AID-SIM625>3.0.CO;2-2     Document Type: Review

References (29)

1. Meta-analysis: Beyond the grand mean?
2. Why sources of heterogeneity in meta-analysis should be investigated
3. Summing up evidence: One answer is not always enough
4. The relation between treatment benefit and underlying risk in meta-analysis
5. Explaining heterogeneity in meta-analysis: A comparison of methods
6. Meta-analysis in clinical research
7. Methods for assessing whether change depends on initial value
8. Letter to the editor: Importance of trends in the interpretation of an overall odds ratio in a meta-analysis of clinical trials
9. Investigating underlying risk as a source of heterogeneity in meta-analysis
10. The population risk as an explanatory variable in research synthesis of clinical trials
11. Variation in baseline risk as an explanation of heterogeneity in meta-analysis
12. Prevention of first bleeding in cirrhosis - A meta-analysis of randomized trials of nonsurgical treatment
13. Bayesian approaches to random effects meta-analyses: A comparative study
14. A language and program for complex Bayesian modelling
15. Letter to the editor: Investigating underlying risk as a source of heterogeneity in meta-analysis
16. Author's reply: Investigating underlying risk as a source of heterogeneity in meta-analysis
17. Inference from iterative simulation using multiple sequences
18. Letter to the editor: Variation in baseline risk as an explanation of heterogeneity in meta-analysis
19. A multilevel model framework for meta-analysis of clinical trials with binary outcomes
20. Meta-analysis in clinical trials
21. A random-effects regression model for meta-analysis
22. Consistent estimators for multilevel generalised linear models using an iterated bootstrap
23. A bivariate approach to meta-analysis
24. A logistic model for trend in 2 x 2 x K tables with applications to meta-analyses
25. An empirical study of the effect of the control rate as a predictor of treatment efficacy in meta-analysis of clinical trials